Parameters group studied (n = 10) | Renal tissue homogenate | ||||
TNF-α (ng/ml) | MDA (nmol/g) | XO (U/g) | NO (µmol/g) | MPO (U/g) | |
Normal control gp. | 5.35bcde ± 0.43 | 1.2bcde ± 0.15 | 1.29bcd ± 0.05 | 0.6bcd ± 0.03 | 2.1bcd ± 0.05 |
Diabetic gp. | 17.78acde ± 0.99 | 3.7acde ± 0.41 | 1.97acde ± 0.08 | 0.8acde ± 0.02 | 3.7acde ± 0.51 |
Ischemic reperfused (IR) gp. | 19.47abde ± 0.82 | 4.8abde ± 0.5 | 2.1abde ± 0.05 | 0.9abde ±0.025 | 6.6abde ± 0.27 |
Diabetic + I/R gp. | 29.15abce ± 0.65 | 6.6abce ± 0.27 | 2.3abce ± 0.03 | 1.3abce ± 0.09 | 8.7abce ± 0.41 |
Sitaglipten treated (Diabetic + I/R) gp. | 6.52abcd ± 0.72 | 1.7abcd ± 0.3 | 1.3bcd ± 0.09 | 0.6bcd ± 0.04 | 2.3bcd ± 0.41 |
F (p) | 1758.387* (<0.001) | 410.522* (<0.001) | 538.407* (<0.001) | 356.989* (<0.001) | 616.495* (<0.001) |
LSD (5%) | 0.667 | 0.311 | 0.057 | 0.040 | 0.327 |